Company: SXTPW
Filing Date: 2025-02-06
Form Type: 8-K
Source: 0001213900-25-010962
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-06
Form: 8-K
Item: Item 1.01
Chunk 2
---
The Company
received net proceeds of approximately $908,627.28 from the offering, after deducting estimated offering expenses paid by the Company,
including the Placement Agent fees. The Company intends to use the net proceeds from the offering forgeneral corporate purposes,
including working capital.

The Engagement Agreement, as amended, form of
Securities Purchase Agreement, form of Warrant, and form of Placement Agent Warrant are filed as Exhibits 1.1, 1.2, 1.3, 10.1, 4.1 and
4.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The above descriptions of the terms of
the Securities Purchase Agreement and Warrant are qualified in their entirety by reference to such exhibits.

Item 3.02. Unregistered Sales of Equity Securities.